Why is Piramal Pharma falling/rising?

As of 16-Jul, Piramal Pharma Ltd's stock price is currently at Rs 214.70, reflecting a decrease of 1.65 (-0.76%). The stock has recently underperformed its sector by 0.49% and has experienced a trend reversal, falling after three consecutive days of gains. Despite this decline, the stock has shown a strong performance over the past week and month, with returns of 6.50% and 7.78%, respectively. The company has reported healthy long-term growth, with operating profit increasing at an annual rate of 286.94%, and has high institutional holdings at 46.27%, indicating confidence from larger investors. However, the stock faces challenges due to a high Debt to EBITDA ratio of 3.21 times and a low Return on Equity of 0.87%, which signifies low profitability per unit of shareholders' funds.
In the broader market context, while Piramal Pharma's stock has generated a return of 40.51% over the past year, significantly outperforming the market's return of 2.38%, it has a year-to-date decline of 19.22%, contrasting with the Sensex's gain of 5.75%. The stock's recent price movement reflects a combination of strong institutional support and positive operational results, tempered by concerns regarding its debt levels and profitability metrics. The stock's liquidity is adequate for trading, but the current price decline suggests that investors may be reacting to the company's financial health and valuation concerns, despite its historical performance.